Alterations in the RB, p16, and Cyclin D1 Cell Cycle Control Pathway in Osteosarcomas

References

• Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin A F, Zeuthen J, et al. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 1996; 56(23)5475–5483
   PubMed Web of Science ®Google Scholar
• Kratzke R A, Greatens T M, Rubins J B, Maddaus M A, Niewoehner D E, Niehans G A, et al. Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res 1996; 56(15)3415–3420
   Google Scholar
• Rozenblum E, Schutte M, Goggins M, Hahn S A, Panzer S, Zahurak M, et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997; 57(9)1731–1734
   PubMed Web of Science ®Google Scholar
• Araki N, Uchida A, Kimura T, Yoshikawa H, Aoki Y, Ueda T, et al. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors. Clin Orthop 1991; 270: 271–277
   PubMedGoogle Scholar
• Benedict W F, Fung Y K, Murphree A L. The gene responsible for the development of retinoblastoma and osteosarcoma. Cancer 1988; 62(8 Suppl)1691–1694
   Google Scholar
• Bridge J A, Nelson M, McComb E, McGuire M H, Rosenthal H, Vergara G, et al. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet 1997; 95(1)74–87
   Google Scholar
• Belchis D A, Meece C A, Benko F A, Rogan P K, Williams R A, Gocke C D. Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas. Diagn Mol Pathol 1996; 5(3)214–219
   PubMedGoogle Scholar
• Dryja T P, Rapaport J M, Epstein J, Goorin A M, Weichselbaum R, Koufos A, et al. Chromosome 13 homozygosity in osteosarcoma without retinoblastoma. Am J Hum Genet 1986; 38(1)59–66
   Google Scholar
• Hansen M F, Koufos A, Gallie B L, Phillips R A, Fodstad O, Brogger A, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 1985; 82(18)6216–6220
   Google Scholar
• Hansen M F. Molecular genetic considerations in osteosarcoma. Clin Orthop 1991; 270: 237–246
   Google Scholar
• Scheffer H, Kruize Y C, Osinga J, Kuiken G, Oosterhuis J W, Leeuw J A, et al. Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma. Cancer Genet Cytogenet 1991; 53(l)45–55
   Google Scholar
• Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki M S, Kotoura Y, et al. Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 1994; 54(11)3042–3048
   PubMed Web of Science ®Google Scholar
• Toguchida J, Ishizaki K, Sasaki M S, Ikenaga M, Sugimoto M, Kotoura Y, et al. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 1988; 48(14)3939–3943
   Google Scholar
• Miller C W, Aslo A, Campbell M J, Kawamata N, Lampkin B C, Koeffler H P. Alterations of the p15, p16, and p18 genes in osteosarcoma. Cancer Genet Cytogenet 1996; 86(2)136–142
   Google Scholar
• Fletcher J A, Gebhardt M C, Kozakewich H P. Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes. Cancer Genet Cytogenet 1994; 77(l)81–88
   Google Scholar
• Nielsen G P, Burns K L, Rosenberg A E, Louis D N. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations. Am J Pathol 1998; 153(1)159–163
   Google Scholar
• Benassi M S, Molendini L, Gamberi G, Sollazzo M R, Ragazzini P, Merli M, et al. Altered Gl phase regulation in osteosarcoma. Int J Cancer 1997; 74(5)518–522
   Google Scholar
• Wen S F, Nodelman M, Nared-Hood K, Duncan J, Geradts J, Shepard H M. Retinoblastoma protein monoclonal antibodies with novel characteristics. J Immunol Methods 1994; 169(2)231–240
   Google Scholar
• Geradts J, Kratzke R A, Crush-Stanton S, Wen S F, Lincoln C E. Wild-type and mutant retinoblastoma protein in paraffin sections. Mod Pathol 1996; 9(3)339–347
   Google Scholar
• Creager A J, Cohen J A, Geradts J. Abrogation of cell cycle control in human mesenchymal neoplasia. Cancer Detect Prevent, in press
   Google Scholar
• Geradts J, Fong K M, Zimmerman P V, Maynard R, Minna J D. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin Cancer Res 1999; 5(4)791–800
   Google Scholar
• Geradts J, Kratzke R A, Niehans G A, Lincoln C E. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995; 55(24)6006–6011
   Google Scholar
• Geradts J, Hu S X, Lincoln C E, Benedict W F, Xu H J. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer 1994; 58(2)161–167
   PubMedGoogle Scholar
• Sarkar F H, Li Y W, Crissman J D. A method for PCR sequencing of the p53 gene from a single 10-microns frozen or paraffin-embedded tissue section. Biotech-niques 1993; 15(1)36–38
   Google Scholar
• Miller C W, Aslo A, Won A, Tan M, Lampkin B, Koeffler H P. Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 1996; 122(9)559–565
   PubMed Web of Science ®Google Scholar
• Toguchida J, Ishizaki K, Sasaki M S, Nakamura Y, Ikenaga M, Kato M, et al. Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 1989; 338(6211)156–158
   Google Scholar
• Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, et al. Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 1992; 52(9)2419–2423
   PubMed Web of Science ®Google Scholar
• Shew J Y, Ling N, Yang X M, Fodstad O, Lee W H. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp11ORB) in osteosarcomas and synovial sarcomas. Oncogene Res 1989; 4(3)205–214
   Google Scholar
• Reissmann P T, Simon M A, Lee W H, Slamon D J. Studies of the retinoblastoma gene in human sarcomas. Oncogene Res 1989; 4(7)839–843
   Google Scholar
• Wei G, Lonardo F, Ueda T, Kim T, Huvos A G, Healey J H, et al. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q 13 amplicons. Int J Cancer 1999; 80(2)199–204
   Google Scholar
• Feugas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P, Babin S, et al. Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 1996; 14(2)467–472
   Google Scholar
• Yoo G H, Xu H J, Brennan J A, Westra W, Hruban R H, Koch W, et al. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994; 54(17)4603–4606
   Google Scholar
• Dodson M K, Cliby W A, Xu H J, DeLacey K A, Hu S X, Keeney G L, et al. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res 1994; 54(3)610–613
   Google Scholar